Is a
Acquisition attributes
Acquired Company
Acquirer
Acquisition Amount (USD)
245,000,000
Date Announced
June 7, 2019
Exonics Therapeutics, a gene-editing therapies company, was acquired by Vertex Pharmaceutical. Vertex agreed to make an upfront payment of $245 million with a definitive agreement for milestone payments that can reach but not exceed $1 billion.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
